ELVN

Enliven Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website enliventherapeutics.com
Employees(FY) 44
ISIN US29337E1029

Performance

+14.98%

-11.49%

-11.36%

-34.93%

-17.11%

YTD

+4.83%

Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. Enliven Therapeutics, Inc. is headquartered in Boulder, Colorado.

Advanced Technical Analysis

Technical Analysis of ELVN 2025-04-29

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 50 indicating stability, while the Oscillators Score at 41 and Technical Score at 45 suggest a lack of strong momentum in either direction. Overall, these scores imply a cautious outlook for the stock, as it hovers in a neutral zone without clear bullish or bear...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ELVN

Stock Rank

Recent News & Updates

2025-04-22 02:54
Enliven Therapeutics: Awaiting Additional Trial Data(Seekingalpha)
2025-04-02 04:03
Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting(Prnewswire)
2025-03-13 04:05
Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update(Prnewswire)
2025-02-25 03:05
Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference(Prnewswire)
2025-01-31 10:10
Enliven Therapeutics (NASDAQ:ELVN) Is In A Good Position To Deliver On Growth Plans(Simply Wall St.)
2025-01-31 07:00
Biotech walks a 'tightrope' amid unclear funding, regulations(Yahoo Finance Video)
2025-01-10 17:37
Enliven Therapeutics Insider Sold Shares Worth $685,868, According to a Recent SEC Filing(MT Newswires)
2024-12-13 07:59
BTIG Initiates Enliven Therapeutics at Buy With $42 Price Target(MT Newswires)
2024-11-13 16:05
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update(PR Newswire)
2024-11-13 03:05
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update(Prnewswire)
2024-11-07 16:05
Enliven Therapeutics to Present at the Jefferies London Healthcare Conference(PR Newswire)
2024-11-07 03:05
Enliven Therapeutics to Present at the Jefferies London Healthcare Conference(Prnewswire)
2024-10-31 08:50
JonesTrading Initiates Enliven Therapeutics at Buy With $36 Price Target(MT Newswires)
2024-10-18 16:38
Why this largely unknown company is one analyst's top biotech pick(Yahoo Finance Video)
2024-10-03 21:00
FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket(Prnewswire)
2024-09-29 16:52
Enliven Therapeutics ELVN-001 shows promise in Phase I CML trial(Yahoo Finance)
2024-09-27 21:35
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia(Globenewswire)
2024-09-25 20:50
Here's Why Momentum in Enliven Therapeutics, Inc. (ELVN) Should Keep going(Yahoo Finance)
2024-09-18 04:05
Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML(Globenewswire)
2024-09-09 02:05
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst(Yahoo Finance)
2024-09-03 21:55
Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High?(Yahoo Finance)
2024-08-15 21:55
Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet(Yahoo Finance)
2024-08-13 04:05
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update(Globenewswire)
2024-05-29 04:05
Enliven Therapeutics to Present at Two Upcoming Investor Conferences(Globenewswire)
2024-05-20 05:06
Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing(Yahoo Finance)
2024-05-14 10:54
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024(Investorplace)
2024-05-14 05:01
Enliven Therapeutics Q1 Loss Narrows(Yahoo Finance)
2024-05-14 04:05
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update(Globenewswire)
2024-04-19 03:03
MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors(Yahoo Finance)
2024-04-11 03:44
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program(Yahoo Finance)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.

ELVN

Performance

Profile

Technical Analysis of ELVN 2025-04-29

Stock Analysis of ELVN

Recent News & Updates

Notifications

Upgrade to Pro

Pro Features Include: